Diagnos, Inc. (ADK.V)
0.41
0.00 (0.00%)
CAD |
TSXV |
Aug 25, 15:35
Diagnos Enterprise Value : 48.24M for Aug. 24, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 48.24M |
| August 21, 2026 | 46.44M |
| August 20, 2026 | 46.44M |
| August 19, 2026 | 47.64M |
| August 18, 2026 | 46.44M |
| August 17, 2026 | 47.04M |
| August 14, 2026 | 44.63M |
| August 13, 2026 | 47.64M |
| August 12, 2026 | 45.83M |
| August 11, 2026 | 45.23M |
| August 10, 2026 | 45.23M |
| August 07, 2026 | 39.21M |
| August 06, 2026 | 38.61M |
| August 05, 2026 | 36.80M |
| August 04, 2026 | 35.60M |
| July 31, 2026 | 32.59M |
| July 30, 2026 | 32.59M |
| July 29, 2026 | 33.79M |
| July 28, 2026 | 34.39M |
| July 27, 2026 | 28.37M |
| July 24, 2026 | 28.37M |
| July 23, 2026 | 27.17M |
| July 21, 2026 | 27.17M |
| July 20, 2026 | 27.17M |
| July 17, 2026 | 26.57M |
| Date | Value |
|---|---|
| July 16, 2026 | 27.17M |
| July 15, 2026 | 30.78M |
| July 14, 2026 | 30.78M |
| July 13, 2026 | 31.38M |
| July 10, 2026 | 31.99M |
| July 09, 2026 | 31.38M |
| July 08, 2026 | 30.78M |
| July 07, 2026 | 31.38M |
| July 06, 2026 | 31.38M |
| July 03, 2026 | 31.99M |
| July 02, 2026 | 30.18M |
| June 30, 2026 | 29.58M |
| June 29, 2026 | 28.37M |
| June 26, 2026 | 27.77M |
| June 25, 2026 | 26.57M |
| June 24, 2026 | 27.17M |
| June 23, 2026 | 27.17M |
| June 22, 2026 | 26.57M |
| June 19, 2026 | 27.77M |
| June 18, 2026 | 26.57M |
| June 17, 2026 | 25.97M |
| June 16, 2026 | 23.56M |
| June 15, 2026 | 22.96M |
| June 12, 2026 | 23.56M |
| June 11, 2026 | 22.35M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Evokai Creative Labs, Inc. | -- |
| Arch Biopartners, Inc. | 80.86M |
| Avricore Health, Inc. | 6.374M |
| Kane Biotech, Inc. | 6.978M |
| CardioComm Solutions, Inc. | 2.62M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.184M |
| Revenue (Quarterly) | 0.0157M |
| Total Expenses (Quarterly) | 1.200M |
| EPS Diluted (Quarterly) | -0.0098 |
| Gross Profit Margin (Quarterly) | -2.24K% |
| Profit Margin (Quarterly) | -7.54K% |
| Earnings Yield | -10.07% |
| Normalized Earnings Yield | -10.12 |